Related references
Note: Only part of the references are listed.A New Prediction Model for Evaluating Treatment-Resistant Depression
Alexander Kautzky et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Pharmacogenetics of antidepressant response: A polygenic approach
Judit Garcia-Gonzalez et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments
Sidney H. Kennedy et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2016)
Clinically Useful Genetic Markers of Antidepressant Response: How Do We Get There From Here?
Francis J. McMahon
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Inflammation and clinical response to treatment in depression: A meta-analysis
R. Strawbridge et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
BDNF as a biomarker for successful treatment of mood disorders: A systematic & quantitative meta-analysis
Maryna Polyakova et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
Longitudinal effects of the SSRI paroxetine on salivary cortisol in Major Depressive Disorder
Henricus G. Ruhe et al.
PSYCHONEUROENDOCRINOLOGY (2015)
A genome-wide association study of antidepressant response in Koreans
W. Myung et al.
TRANSLATIONAL PSYCHIATRY (2015)
The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
J. M. Biernacka et al.
TRANSLATIONAL PSYCHIATRY (2015)
Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis
B. S. Fernandes et al.
MOLECULAR PSYCHIATRY (2014)
Increased cortisol awakening response was associated with time to recurrence of major depressive disorder
Florian Hardeveld et al.
PSYCHONEUROENDOCRINOLOGY (2014)
Contribution of Common Genetic Variants to Antidepressant Response
Katherine E. Tansey et al.
BIOLOGICAL PSYCHIATRY (2013)
CRP, IL-6 and depression: A systematic review and meta-analysis of longitudinal studies
Vyara Valkanova et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Whole-exome sequencing identifies a polymorphism in the BMP5 gene associated with SSRI treatment response in major depression
Anu Tammiste et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Possible association of CUX1 gene polymorphisms with antidepressant response in major depressive disorder
D. Sasayama et al.
PHARMACOGENOMICS JOURNAL (2013)
Lower cortisol levels predict recurrence in remitted patients with recurrent depression: A 5.5 year prospective study
Claudi L. H. Bockting et al.
PSYCHIATRY RESEARCH (2012)
Longitudinal hypothalamic-pituitary-adrenal axis trait and state effects in recurrent depression
Anja Lok et al.
PSYCHONEUROENDOCRINOLOGY (2012)
Treatment-resistant depression: therapeutic trends, challenges, and future directions
Khalid Saad Al-Harbi
PATIENT PREFERENCE AND ADHERENCE (2012)
The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis
Jonas Hannestad et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Serum BDNF levels before treatment predict SSRI response in depression
Owen M. Wolkowitz et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Genome-Wide Pharmacogenetics of Antidepressant Response in the GENDEP Project
Rudolf Uher et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
A Genomewide Association Study of Citalopram Response in Major Depressive Disorder
Holly A. Garriock et al.
BIOLOGICAL PSYCHIATRY (2010)
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
M. Kato et al.
MOLECULAR PSYCHIATRY (2010)
A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression
Marcus Ising et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Associations between sociodemographic, sampling and health factors and various salivary cortisol indicators in a large sample without psychopathology
Sophie A. Vreeburg et al.
PSYCHONEUROENDOCRINOLOGY (2009)
The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders
Elisabeth B. Binder
PSYCHONEUROENDOCRINOLOGY (2009)
Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
M. Bryant Howren et al.
PSYCHOSOMATIC MEDICINE (2009)
Current trends in the assessment and somatic treatment of resistant/refractory major depression: An overview
Marcelo T. Berlim et al.
ANNALS OF MEDICINE (2008)
A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression
Andre Russowsky Brunoni et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
How can we realize the promise of personalized antidepressant medicines?
Florian Holsboer
NATURE REVIEWS NEUROSCIENCE (2008)
The assessment of poststroke depression
Katherine Salter et al.
TOPICS IN STROKE REHABILITATION (2007)
Measuring personality in one minute or less: A 10-item short version of the Big Five Inventory in English and German
Beatrice Rammstedt et al.
JOURNAL OF RESEARCH IN PERSONALITY (2007)
Medication augmentation after the failure of SSRIs for depression
MH Trivedi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Development of a new resilience scale: The Connor-Davidson Resilience scale (CD-RISC)
KM Connor et al.
DEPRESSION AND ANXIETY (2003)
Pharmacogenetics:: a new diagnostic tool in the management of antidepressive drug therapy
W Steimer et al.
CLINICA CHIMICA ACTA (2001)
Share Paper
